Abstract
Hypertension is a common complication among post cardiac transplant recipients affecting more than 95% of patients. Increased blood pressure poses a significant cardiovascular morbidity and mortality in these patients; it should be identified quickly and needs to be managed appropriately. Understanding the pathophysiology and contributing factors to this disease in these complex and unique patients is the key to appropriate treatment selection.
Keywords:
Calcineurin inhibitors; Cardiac transplantation; Hypertension.
Copyright © 2016 Elsevier Inc. All rights reserved.
MeSH terms
-
Adrenal Cortex Hormones / adverse effects
-
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
-
Antihypertensive Agents / therapeutic use*
-
Autonomic Denervation / adverse effects
-
Calcineurin Inhibitors / adverse effects*
-
Calcineurin Inhibitors / pharmacology
-
Calcium Channel Blockers / therapeutic use
-
Diuretics / therapeutic use
-
Heart / innervation
-
Heart Transplantation / adverse effects*
-
Hemodynamics
-
Humans
-
Hypertension / drug therapy*
-
Hypertension / etiology
-
Hypertension / physiopathology*
-
Immunosuppressive Agents / adverse effects
-
Vasodilator Agents / therapeutic use
Substances
-
Adrenal Cortex Hormones
-
Angiotensin-Converting Enzyme Inhibitors
-
Antihypertensive Agents
-
Calcineurin Inhibitors
-
Calcium Channel Blockers
-
Diuretics
-
Immunosuppressive Agents
-
Vasodilator Agents